1. Home
  2. CPIX vs ICMB Comparison

CPIX vs ICMB Comparison

Compare CPIX & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • ICMB
  • Stock Information
  • Founded
  • CPIX 1999
  • ICMB 2012
  • Country
  • CPIX United States
  • ICMB United States
  • Employees
  • CPIX N/A
  • ICMB N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • ICMB Finance: Consumer Services
  • Sector
  • CPIX Health Care
  • ICMB Finance
  • Exchange
  • CPIX Nasdaq
  • ICMB Nasdaq
  • Market Cap
  • CPIX 40.1M
  • ICMB 40.6M
  • IPO Year
  • CPIX 2009
  • ICMB N/A
  • Fundamental
  • Price
  • CPIX $3.44
  • ICMB $2.85
  • Analyst Decision
  • CPIX
  • ICMB
  • Analyst Count
  • CPIX 0
  • ICMB 0
  • Target Price
  • CPIX N/A
  • ICMB N/A
  • AVG Volume (30 Days)
  • CPIX 81.2K
  • ICMB 19.4K
  • Earning Date
  • CPIX 08-05-2025
  • ICMB 09-24-2025
  • Dividend Yield
  • CPIX N/A
  • ICMB 16.87%
  • EPS Growth
  • CPIX N/A
  • ICMB N/A
  • EPS
  • CPIX N/A
  • ICMB 0.82
  • Revenue
  • CPIX $41,083,299.00
  • ICMB $20,996,189.00
  • Revenue This Year
  • CPIX N/A
  • ICMB N/A
  • Revenue Next Year
  • CPIX N/A
  • ICMB N/A
  • P/E Ratio
  • CPIX N/A
  • ICMB $3.45
  • Revenue Growth
  • CPIX 5.82
  • ICMB N/A
  • 52 Week Low
  • CPIX $1.04
  • ICMB $2.46
  • 52 Week High
  • CPIX $7.25
  • ICMB $3.47
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 46.28
  • ICMB 52.08
  • Support Level
  • CPIX $3.25
  • ICMB $2.76
  • Resistance Level
  • CPIX $3.97
  • ICMB $2.87
  • Average True Range (ATR)
  • CPIX 0.36
  • ICMB 0.08
  • MACD
  • CPIX 0.07
  • ICMB 0.00
  • Stochastic Oscillator
  • CPIX 45.36
  • ICMB 66.67

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About ICMB Investcorp Credit Management BDC Inc.

Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.

Share on Social Networks: